Subscribe to our RSS feeds RSS    
 

News

Acrylamide May Hike Renal Cell Cancer Risk

Jody A. Charnow May 08, 2008

DIETARY INTAKE of acrylamide, a probable human carcinogen, may be associated with an increased risk of renal cell cancer, according to a report in the American Journal of Clinical Nutrition (2008;87:1428-1438).
 

N-3 Fatty Acids May Lower HD Patients' Triglycerides

Jody A. Charnow May 08, 2008

Treatment with n-3 polyunsaturated acids (PUFA) may help hemodialysis (HD) patients lower serum triglyceride levels, according to a report in Nephrology Dialysis Transplantation (2008; published online ahead of print).
 

Racial Disparity in Diabetes Control

John Schieszer May 06, 2008

DIABETES CONTROL may be more challenging for Hispanics than for non-Hispanic whites, a meta-analysis suggests.
 

Graft Loss Risk Linked to Employment

Jody A. Charnow May 06, 2008

RENAL GRAFT LOSS is less likely among transplant recipients who are employed full time when they get their kidneys and at one year postoperatively, according to researchers.
 

Sextant Biopsy Alone May Miss Tumors

Jody A. Charnow May 06, 2008

PROSTATE BIOPSIES in men with a PSA level of 4.01-10.0 ng/mL and normal findings on digital rectal examination (DRE) should include lateral cores in addition to the sextant biopsy, according to investigators.
 

NSAIDs Lower PCa Death Risk

Jody A. Charnow May 06, 2008

SAN FRANCISCO—High exposure to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is asso-ciated with decreased prostate cancer-specific mortality, according to study findings presented here at the 2008 Genitourinary Cancers Symposium.
 

Lower PSAV Threshold Useful

Jody A. Charnow May 06, 2008

SAN FRANCISCO—A PSA velocity (PSAV) threshold of 0.4 ng/mL per year can distinguish between clinically significant and insignificant prostate cancer, new data suggest.
 

Untreated PCa Seldom Fatal in Elderly

Jody A. Charnow May 06, 2008

SAN FRANCISCO—Few elderly men with localized prostate cancer will die from the malignancy after 10 years even in treatment is delayed, so active surveillance for these patients may be a reasonable option, according to researchers.
 

Study: Combo Promising for Metastatic AIPC

Jody A. Charnow May 06, 2008

SAN FRANCISCO—Adding thalidomide and bevacizumab to docetaxel may hold promise for treating patients with metastatic androgen-independent prostate cancer (AIPC), investigators report.
 

AMA: Damage Caps Keep Lid on Premiums

Myra Dembrow May 06, 2008

Laws that limit certain damage awards in malpractice cases are limiting insurance premiums, too.
 
 Subscribe to the RSS for this page  [view all our RSS feeds here]
 
A Haymarket Media, Inc website
Home | News | Departments | Editorial Board | Contact | Subscribe | Advertise | About
From Haymarket Medical the Publishers of:
Monthly Prescribing Reference Nurse Practitioners' Prescribing Reference Physician Assistants' Prescribing Reference
Cortlandt Forum McKnight's Long-Term Care News Renal & Urology News The Clinical Advisor JAAPA McKnight's Assisted Living